CA2752003A1 - Ceramide-analogous metabolites - Google Patents

Ceramide-analogous metabolites Download PDF

Info

Publication number
CA2752003A1
CA2752003A1 CA2752003A CA2752003A CA2752003A1 CA 2752003 A1 CA2752003 A1 CA 2752003A1 CA 2752003 A CA2752003 A CA 2752003A CA 2752003 A CA2752003 A CA 2752003A CA 2752003 A1 CA2752003 A1 CA 2752003A1
Authority
CA
Canada
Prior art keywords
compound
iii
compounds
pharmaceutical composition
alkyl chain
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA2752003A
Other languages
English (en)
French (fr)
Inventor
Guido Jordine
Markus Zollinger
Claudia Sayer
Volker Brinkmann
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
Novartis AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis AG filed Critical Novartis AG
Publication of CA2752003A1 publication Critical patent/CA2752003A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C233/16—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms
    • C07C233/17—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom
    • C07C233/18—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom having the carbon atom of the carboxamide group bound to a hydrogen atom or to a carbon atom of an acyclic saturated carbon skeleton

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Transplantation (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
CA2752003A 2009-02-24 2010-02-23 Ceramide-analogous metabolites Abandoned CA2752003A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP09153550.0 2009-02-24
EP09153550 2009-02-24
PCT/EP2010/052231 WO2010097371A1 (en) 2009-02-24 2010-02-23 Ceramide-analogous metabolites

Publications (1)

Publication Number Publication Date
CA2752003A1 true CA2752003A1 (en) 2010-09-02

Family

ID=40447014

Family Applications (1)

Application Number Title Priority Date Filing Date
CA2752003A Abandoned CA2752003A1 (en) 2009-02-24 2010-02-23 Ceramide-analogous metabolites

Country Status (14)

Country Link
US (1) US8673982B2 (cg-RX-API-DMAC7.html)
EP (1) EP2400960B1 (cg-RX-API-DMAC7.html)
JP (1) JP2012518671A (cg-RX-API-DMAC7.html)
KR (1) KR20110126631A (cg-RX-API-DMAC7.html)
CN (1) CN102333530A (cg-RX-API-DMAC7.html)
AU (1) AU2010217605B2 (cg-RX-API-DMAC7.html)
BR (1) BRPI1007994A2 (cg-RX-API-DMAC7.html)
CA (1) CA2752003A1 (cg-RX-API-DMAC7.html)
ES (1) ES2411138T3 (cg-RX-API-DMAC7.html)
MX (1) MX2011008876A (cg-RX-API-DMAC7.html)
PL (1) PL2400960T3 (cg-RX-API-DMAC7.html)
PT (1) PT2400960E (cg-RX-API-DMAC7.html)
RU (1) RU2011138963A (cg-RX-API-DMAC7.html)
WO (1) WO2010097371A1 (cg-RX-API-DMAC7.html)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2888634C (en) * 2012-10-19 2019-10-08 Ruth Perez Compositions and methods for the treatment of parkinson's disease
HK1212324A1 (en) * 2012-11-30 2016-06-10 株式会社爱茉莉太平洋 Novel pseudoceramide compound and production method for same
AU2014224237B2 (en) * 2013-03-05 2017-07-20 Biocon Limited A process for the preparation of 2-amino-1,3-propane diol compounds and salts thereof
KR101510683B1 (ko) 2013-09-03 2015-04-10 (주)네오팜 카나비노이드 수용체에 길항작용을 가지는 신규한 유사 세라마이드 유도체 및 이를 포함하는 약학 또는 화장품 조성물
EP3118621A1 (en) 2015-07-14 2017-01-18 Fundació Institut d'Investigació Biomèdica de Bellvitge (IDIBELL) Methods and compositions for the diagnosis and for the treatment of adrenoleukodystrophy

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR0155015B1 (ko) * 1992-10-21 1998-12-01 고우야 마사시 2-아미노-1,3-프로판디올 화합물 및 면역 억제제
US5948820A (en) * 1994-08-22 1999-09-07 Yoshitomi Pharmaceutical Industries, Ltd. Benzene compound and pharmaceutical use thereof
DE69524962T4 (de) * 1994-08-22 2003-08-28 Mitsubishi Pharma Corp., Osaka Benzolderivate und deren medizinische verwendung
PL1773307T3 (pl) * 2004-07-30 2015-03-31 Novartis Ag Preparaty 2-amino-1,3-propanodioli i ich analogów
GT200600350A (es) * 2005-08-09 2007-03-28 Formulaciones líquidas
RU2433117C2 (ru) * 2005-12-15 2011-11-10 Мицубиси Танабе Фарма Корпорейшн Аминное соединение и его применение в медицинских целях
CN101240002B (zh) * 2007-02-07 2011-01-26 首都医科大学 脂肪酰氨基酰阿糖胞苷缀合物、其制备方法和应用

Also Published As

Publication number Publication date
RU2011138963A (ru) 2013-04-10
US20110306672A1 (en) 2011-12-15
ES2411138T3 (es) 2013-07-04
MX2011008876A (es) 2011-09-21
EP2400960B1 (en) 2013-04-17
PL2400960T3 (pl) 2013-08-30
EP2400960A1 (en) 2012-01-04
AU2010217605B2 (en) 2012-07-26
KR20110126631A (ko) 2011-11-23
AU2010217605A1 (en) 2011-08-18
PT2400960E (pt) 2013-06-28
JP2012518671A (ja) 2012-08-16
WO2010097371A1 (en) 2010-09-02
US8673982B2 (en) 2014-03-18
BRPI1007994A2 (pt) 2018-03-13
CN102333530A (zh) 2012-01-25

Similar Documents

Publication Publication Date Title
AU2009315735B2 (en) Salts of fingolimod
US9415024B2 (en) Aminoalkanol derivatives
EP2400960B1 (en) Ceramide-analogous metabolites
US7326801B2 (en) 2-amino-propanol derivatives
US20160317479A1 (en) Method of treating or preventing pain
US9133096B2 (en) Process for the production of 2-amino-2[2-(4-C2-20-alkyl-phenyl)ethyl]propane-1,3-diols, and to compounds for use therein
RU2196130C2 (ru) Производные аминоэтилфеноксиуксусной кислоты и лекарственные средства для успокоения боли и облегчения отхождения камней при мочекаменной болезни
HK1093061B (en) Aminoalkanol derivatives
JP2005060311A (ja) N−(ベンゾイル)アミノ酸誘導体を有効成分とするニューロパシー性疼痛治療剤
AU2013203470A1 (en) Salts of fingolimod
EP0302934A1 (en) Alicyclic dicarboxylic acid derivatives and muscle relaxants containing them as effective ingredients
AU2013263791A1 (en) Crystalline forms of fingolimod HCL

Legal Events

Date Code Title Description
FZDE Discontinued

Effective date: 20160223